earnings

Puma shares plummet as results from key trial delayed
Puma shares plummet as results from key trial delayed
Biopharma Dive
Puma Biotechnology
earnings
Nerlynx
clinical trials
Flag link:
MannKind Q1 Results: The Good, the Bad, and the Ugly
MannKind Q1 Results: The Good, the Bad, and the Ugly
Motley Fool
MannKind
earnings
Flag link:
bluebird bio Looks for Data Ahead
bluebird bio Looks for Data Ahead
Motley Fool
Bluebird Bio
earnings
Flag link:
Mylan Faces EpiPen Shortage as Slowing Sales Trip Up Its Results
Mylan Faces EpiPen Shortage as Slowing Sales Trip Up Its Results
Bloomberg
Mylan Labs
earnings
EpiPens
Flag link:
Novo Nordisk Fights Payer Pressure With New Meds
Novo Nordisk Fights Payer Pressure With New Meds
Motley Fool
Novo Nordisk
earnings
Flag link:
Editas Medicine Starts a "Transformative" Year on a High Note
Editas Medicine Starts a "Transformative" Year on a High Note
Motley Fool
Editas Medicine
earnings
CRISPR
Flag link:
Celgene Rises As Q1 Earnings, Sales Top Views
Celgene Rises As Q1 Earnings, Sales Top Views
Investors Business Daily
Celgene
earnings
Flag link:
Earnings Preview: What To Expect From Celgene On Friday
Earnings Preview: What To Expect From Celgene On Friday
Forbes
Celgene
earnings
Flag link:
Regeneron (REGN) Q1 Earnings Top, Sales Lag, Updates View
Regeneron (REGN) Q1 Earnings Top, Sales Lag, Updates View
Yahoo/Zacks.com
Regeneron
earnings
Flag link:
Seattle Genetics Accelerates Revenue Growth, Earnings Not So Much
Seattle Genetics Accelerates Revenue Growth, Earnings Not So Much
Motley Fool
Seattle Genetics
earnings
Flag link:
Another disappointing quarter from Gilead, shares down almost 6%
Another disappointing quarter from Gilead, shares down almost 6%
GoinPharma
Gilead Sciences
earnings
Flag link:
Earnings Preview: What To Expect From Teva On Thursday
Earnings Preview: What To Expect From Teva On Thursday
Forbes
Teva Pharmaceutical
earnings
Flag link:
Pfizer tops earnings estimates, driven by sales of pneumonia vaccine Prevnar
Pfizer tops earnings estimates, driven by sales of pneumonia vaccine Prevnar
CNBC
Pfizer
earnings
Flag link:
Merck posts strong first-quarter profit, but revenue light
Merck posts strong first-quarter profit, but revenue light
Yahoo/AP
Merck
earnings
Flag link:
GSK's Shingrix blows past sales projections, pushing 2018 estimates to $600M
GSK's Shingrix blows past sales projections, pushing 2018 estimates to $600M
Fierce Pharma
GSK
vaccines
earnings
Shingrix
shingles
Flag link:
AbbVie's First Quarter: Trying to Replace Humira Sales
AbbVie's First Quarter: Trying to Replace Humira Sales
Yahoo/Motley Fool
AbbVie
earnings
Humira
Flag link:
What to Expect With Gilead Sciences Inc.'s Q1 Earnings Results
What to Expect With Gilead Sciences Inc.'s Q1 Earnings Results
Motley Fool
Gilead Sciences
earnings
Flag link:
What to Expect with Pfizer's Q1 Results
What to Expect with Pfizer's Q1 Results
Motley Fool
Pfizer
earnings
Flag link:
Allergan: Q1 Results Could Convince Bulls Growth Is Dead
Allergan: Q1 Results Could Convince Bulls Growth Is Dead
Seeking Alpha
Allergan
earnings
Flag link:
BioMarin Cruises While It Waits on Seventh Approval
BioMarin Cruises While It Waits on Seventh Approval
Motley Fool
Biomarin
pegvaliase
FDA
PKU
earnings
Flag link:

Pages